Smart Search
Share Results
| COMPANY | SYMBOL | TYPE | PRICE | Shares | Trade Date | UNDERWRITER (S) |
| Akoya Biosciences, Inc. | AKYA | IPO | $18.00-$20.00 | 6.6 million | 4/16/2021 | JP Morgan, Morgan Stanley, Piper Sandler, Canaccord Genuity |
| AutoGenomics, Inc. | AGMX | IPO | $11.00-$13.00 | 3.75 million | 0/0/0 | Stifel, Canaccord Genuity, Cantor Fitzgerald & Co. |
| Avinger, Inc. | AVGR | IPO | $12.00-$14.00 | 5 million | 1/30/2015 | Canaccord Genuity, Cowen & Co. |
| Candela Medical, Inc. | CDLA | IPO | Postponed | Postponed | 10/28/2021 | BofA Securities, Goldman Sachs, Barclays, Baird, Canaccord Genuity, Stifel |
| Cardiva Medical Inc | TBD | IPO | Withdrawn | Withdrawn | 1/0/2021 | J.P. Morgan, BofA Securities, Canaccord Genuity, Stifel |
| Ellipse Technologies, Inc. | MGEC | IPO | TBD | TBD | 0/0/0 | Piper Jaffray, William Blair, Canaccord Genuity |
| Greenlane Holdings, Inc. | GNLN | IPO | $14.00-$16.00 | 6 million | 4/18/2019 | Cowen, Canaccord Genuity |
| Histogenics Corporation | HSGX | IPO | $13.00-$15.00 | 5.91 million | 12/3/2014 | Cowen & Co., Needham & Co., Canaccord Genuity |
| Infraredx, Inc. | REDX | IPO | $13.00-$15.00 | 4 million | 0/0/0 | RBC Capital Markets, Canaccord Genuity, BMO Capital Markets |
| InMode Ltd. | INMD | IPO | $14.00-$16.00 | 5 million | 8/8/2019 | Barclays, UBS Investment Bank, Canaccord Genuity |
| Iris Energy Limited | IREN | IPO | $25.00-$27.00 | 8.3 million | 11/17/2021 | J.P. Morgan, Canaccord Genuity, Citigroup |
| Laird Superfood, Inc. | LSF | IPO | $21.00-$22.00 | 2.65 million | 9/23/2020 | Canaccord Genuity, Craig-Hallum Capital Group |
| Lucid Diagnostics, Inc. | LUCD | IPO | $14.00-$16.00 | 5 million | 10/14/2021 | Cantor, Canaccord Genuity |
| MediaAlpha, Inc. | MAX | IPO | $18.00-$20.00 | 9.25 million | 10/28/2020 | J.P. Morgan, Citigroup, Credit Suisse, RBC Capital Markets, Canaccord Genuity, William Blair |
| Motorsport Gaming US LLC | MSGM | IPO | $19.00-$20.00 | 3 million | 1/13/2021 | Canaccord Genuity, The Benchmark Company |
| Obalon Therapeutics | OBLN | IPO | $14.00-$16.00 | 5 million | 10/6/2016 | UBS Investment Bank, Canaccord Genuity, Stifel |
| Olema Pharmaceuticals, Inc. | OLMA | IPO | $16.00-$18.00 | 11 million | 11/19/2020 | J.P. Morgan, Jefferies, Cowen, Canaccord Genuity ​ |
| Perspectum Group plc | SCAN | IPO | Withdrawn | Withdrawn | 7/16/2021 | Citigroup, Barclays, Stifel, Canaccord Genuity |
| Privia Health Group, Inc. | PRVA | IPO | $21.00-$23.00 | 19.5 million | 4/29/2021 | Goldman Sachs, JP Morgan, Credit Suisse, Piper Sandler, William Blair, Canaccord Genuity, Truist Securities |
| Qualtrics International Inc. | XM | IPO | $27.00-$29.00 | 50.4 million | 1/28/2021 | Morgan Stanley, J.P. Morgan, BofA Securities, Barclays, Deutsche Bank Securities, Goldman Sachs, HSBC, Citigroup, BMO Capital Markets, Truist Securities, Canaccord Genuity, Evercore ISI, JMP Securities, Oppenheimer & Co., Piper Sandler, Raymond James, William Blair |
| Rani Therapeutics Inc. | RANI | IPO | $14.00-$16.00 | 6.67 million | 7/30/2021 | BofA Securities, Stifel, Cantor, Canaccord Genuity |
| SCYNEXIS, Inc. | SCYX | IPO | $10.00-$10.00 | 6.2 million | 5/2/2014 | RBC Capital Markets, Canaccord Genuity |
| Sigilon Therapeutics, Inc. | SGTX | IPO | $17.00-$19.00 | 7 million | 12/4/2020 | Morgan Stanley, Jefferies, Barclays, Canaccord Genuity |
| Sportradar Group AG | SRAD | IPO | $25.00-$28.00 | 19 million | 9/14/2021 | JP Morgan, Morgan Stanley, Citigroup, UBS Investment Bank, BofA Securities, Deutsche Bank Securities, Jefferies, Canaccord Genuity |
| SurgiQuest, Inc. | TBD | IPO | TBD | TBD | 0/0/0 | Piper Jaffray, Stifel, Canaccord Genuity |
| Tactile Systems Technology | TCMD | IPO | $14.00-$16.00 | 4 million | 7/28/2016 | Piper Jaffray, William Blair, Canaccord Genuity |
| Taylor & Martin Group | TMG | IPO | $8.00-$10.00 | 19 million | 0/0/0 | Canaccord Genuity, Oppenheimer & Co., KeyBanc Capital Markets, Stephens Inc. |
| TELA Bio, Inc. | TELA | IPO | $14.00-$16.00 | 4 million | 11/8/2019 | Jefferies, Piper Jaffray, Canaccord Genuity |
| Winc, Inc. | WBEV | IPO | Postponed | Postponed | 10/21/2021 | BofA Securities, Canaccord Genuity, Craig-Hallum, Roth Capital |
| Y-mAbs Therapeutics, Inc. | YMAB | IPO | $14.00-$16.00 | 6 million | 9/21/2018 | BofA Merrill Lynch, Cowen, Canaccord Genuity |
IPO Boutique advisories are available with your choice of a monthly or annual payment.
To subscribe to IPO Boutique click:
© 2005 - 2024 IPO Boutique. All Rights Reserved